+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07160270

Study of Neuropathy Causes, Symptoms, and Biomarkers in Patients with Waldenstrms Macroglobulinemia to Improve Diagnosis and Care

Led by Rigshospitalet, Denmark · Updated on 2025-09-08

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Neuropathy greatly impacts patients by causing sensory loss, chronic pain, and difficulty moving arms and legs. This research focuses on neuropathy linked to Waldenstrms Macroglobulinemia WM, a specific lymphoma type involving abnormal B cells and IgM protein. WM-related neuropathy varies widely, from mild symptoms to severe loss of movement and pain. Early treatment of WM may slow disease and nerve damage, but identifying neuropathy caused by WM versus other reasons can be challenging. The study is a cross-sectional observational design aiming to find how common neuropathy is among WM patients and to understand its clinical subtypes and underlying mechanisms. Researchers will use questionnaires, neurological exams, nerve conduction studies, blood tests, and cerebrospinal fluid analysis to investigate patients. About 90 patients with symptoms of neuropathy associated with WM will be clinically examined and tested over one year, with a three-year follow-up period. Participants will complete questionnaires and undergo physical and paraclinical assessments including nerve conduction studies and sample collections. Blood tests will analyze markers related to neuropathy, inflammation, and infections, while cerebrospinal fluid will be tested for related proteins and cells. The study will measure how many WM patients have neuropathy and assess the disability caused by it. Data will help improve diagnosis, monitoring, and treatment approaches to maintain patient mobility and quality of life.

CONDITIONS

Brief Title

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

Research Team

M

Morten Müller Aagaard, Medical Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here